Literature DB >> 32075206

Measles Immunization Policies and Vaccination Coverage in EU/EEA Countries over the Last Decade.

Marco Montalti1, Anna Kawalec2, Erica Leoni1, Laura Dallolio1.   

Abstract

BACKGROUND: Starting from 2016, a major measles epidemic affected EU/EEA countries, after the measles incidence rate had progressively decreased from 2011 to 2015.
METHODS: This study describes measles incidences (ECDC reports), the vaccination coverages (VCs) (WHO/UNICEF reports) and the vaccination strategies, whether mandatory or recommended (ECDC Vaccine Scheduler), in 30 European countries over the last decade.
RESULTS: VCs were higher in countries with historically mandatory vaccination. However, in these countries, VCs declined between 2010 and 2018, in two cases to levels below 90% at the second dose. Instead, 9 and 12 countries with recommended vaccination increased their VCs, respectively, for the first and the second dose. Overall, the countries with VC ≥ 95% decreased from 20 to 15 for the first dose and from 10 to 7 for the second dose. This trend led Italy, France and Germany to make vaccination mandatory. In Italy this provision was introduced in 2017, and together with the catch-up campaigns on children between 1 and 15 years at school entry, led immediately to a strong effect: the first dose VC passed from 87% in 2016 to 93% in 2018, and from 82% to 89% for the second dose.
CONCLUSIONS: Mandatory vaccination is certainly a policy producing positive effects; however, it seems to require additional strategies in order to reach the WHO goal of 95% of VC. Measures such as catch-up action on susceptible populations and communication strategies aimed at increasing awareness and acceptance should be considered.

Entities:  

Keywords:  European countries; mandatory vaccination; measles; recommended vaccination; vaccination coverage

Year:  2020        PMID: 32075206     DOI: 10.3390/vaccines8010086

Source DB:  PubMed          Journal:  Vaccines (Basel)        ISSN: 2076-393X


  5 in total

Review 1.  Evolving measles status and immunization policy development in six European countries.

Authors:  Ivo Vojtek; Heidi Larson; Stanley Plotkin; Pierre Van Damme
Journal:  Hum Vaccin Immunother       Date:  2022-02-18       Impact factor: 4.526

2.  Humoral Immunity against Measles in Mother-Infant Pairs during the First Year of Life in Greece: A Cross-Sectional Study.

Authors:  Florentia Kanakoudi-Tsakalidou; Evangelia Farmaki; Eleni Papadimitriou; Anna Taparkou; Eleni Agakidou; Styliani Glykou; Fotiοs Papachristou
Journal:  Vaccines (Basel)       Date:  2021-02-10

3.  Gender differences in measles incidence rates in a multi-year, pooled analysis, based on national data from seven high income countries.

Authors:  Manfred S Green; Naama Schwartz; Victoria Peer
Journal:  BMC Infect Dis       Date:  2022-04-11       Impact factor: 3.090

4.  An Overview of Strategies to Improve Vaccination Compliance before and during the COVID-19 Pandemic.

Authors:  Lorena Charrier; Jacopo Garlasco; Robin Thomas; Paolo Gardois; Marco Bo; Carla Maria Zotti
Journal:  Int J Environ Res Public Health       Date:  2022-09-03       Impact factor: 4.614

5.  How Public Health Professionals View Mandatory Vaccination in Italy-A Cross-Sectional Survey.

Authors:  Erica Pitini; Valentina Baccolini; Annalisa Rosso; Azzurra Massimi; Corrado De Vito; Carolina Marzuillo; Paolo Villari
Journal:  Vaccines (Basel)       Date:  2021-06-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.